您的位置: 首页 > 农业专利 > 详情页

Human antibodies to human CD20 and method of using thereof
专利权人:
Inc.;Regeneron Pharmaceuticals
发明人:
Stevens, Sean,Wang, Li-Hsien,Martin, Joel H.,Allison, Erin M.
申请号:
AU2008282152
公开号:
AU2008282152B2
申请日:
2008.07.31
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
A human antibody or antigen-binding fragment of an antibody that specificallybinds human CD20 and is capable of inducing complement dependent cytotoxicity(CDC), and is capable of increasing symptom free survival time between about2-fold to about 9-fold or more, relative to control-treated animals in a mousemodel of human lymphoma. The antibody or antigen-binding fragment thereof isuseful in a therapeutic method for treating a CD20-mediated disease or condition,such as for example, non-Hodgkin's lymphoma, rheumatoid arthritis, systemiclupus erythematosus, Crohn's disease, chronic lymphocytic leukemia,and inflammatory diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充